Elevance Health Inc Earns High Ratings in Guru Report

Elevance Health Inc shines with a strong 79% rating based on multiple growth factors. This rating suggests potential investor interest, especially in the slowly recovering Insurance market.

Date: 29-01-2025

AI Rating: 7

EPS Growth and Performance
Elevance Health Inc (ELV) received a favorable rating of 79% based on the Low PE Investor strategy. This model emphasizes consistent earnings growth, and ELV demonstrates a 'PASS' in EPS Growth and Future EPS Growth, indicating a positive outlook. The fact that they meet the requirements for these criteria suggests robust earnings performance is expected in the near term.

Sales Growth
Alongside positive EPS Growth, ELV also achieved a 'PASS' in Sales Growth. This implies that not only is the company expected to maintain earnings, but it is also likely to see increased revenue, a critical factor for stock price appreciation.

Free Cash Flow
Another essential indicator for investors is Free Cash Flow, which ELV has also passed. Positive Free Cash Flow allows the company to reinvest in growth opportunities, pay dividends, and pay down debt, providing reassurance to investors about the company's financial health.

Negative Indicators
Despite the positives, there are concerns. ELV received 'FAIL' scores regarding Total Return/PE and EPS Persistence. This may indicate that while the company shows potential for growth, it hasn't consistently rewarded shareholders or maintained stable earnings, which can alarm potential investors.

Overall, Elevance Health Inc shows potential for growth given its high EPS and sales growth prospects. However, negative ratings in other critical areas lead to cautious optimism as investors consider these factors in stock price valuation.

Stocks: ELV